"Research Article"
American Journal of BioMedicine Volume 3, Issue 1, pages 32-43, January 2015
doi: 10.18081/ajbm/2333-5106-015-01/32-43
Najah R. Hadi, Bassim I. Mohammad, Hussam Alfatlawi, Heider S. Qassam, Sahar Alhar, Tahir Hussain
Abstract
The objective of this study to evaluate the effect of the combination of aspirin and clopidogrel in low doses on the progression of atherosclerosis. A total of 35 local domestic rabbits was assigned to five groups. Blood samples were collected at the end of the experiment (8-weeks) for measurement of serum triglycerides, total cholesterol (TC), HDL-C, plasma high sensitive C-reactive protein, plasma malondialdehyde and plasma reduced glutathione. Compared to normal control, levels of lipid profile, atherogenic index, hsCRP, and MDA are increased while GSH were decreased in animals on an atherogenic diet. Immunohistochemical analysis showed that aortic expression of VCAM-1, MCP-1, TNF-α and IL-17A were significantly increased in the atherogenic control group compared to a normal control group. A combination of low doses aspirin and clopidogrel causes statistically significant reduction in hsCRP and MDA. A combination of low doses aspirin and clopidogrel treatment significantly reduced aortic expression of VCAM-1, MCP-1, TNF-α and IL-17A. Histopathologic examination of aortic arch showed that the combination of low doses aspirin and clopidogrel significantly reduced atherosclerotic lesion. Aspirin treatment considerably reduced aortic expression of VCAM-1, MCP-1, TNF-α and IL-17A. It thus can conclude that a combination of aspirin and clopidogrel in low doses has a reducing effect on lipid peroxidation, systemic inflammation and aortic expression of inflammatory marker and hence reduce the progression of atherosclerosis.
Keywords: Atherosclerosis; Combination of aspirin and clopidogrel; Aspirin; Oxidative stress
Open Access Full Text-PDF Feedback
References
1. Schoenhagen Crowe T, Tuzcu M, Steven E Nissen. Pharmacological strategies for the prevention of atherosclerotic plaque regression. Expert Rev Cardiovasc Ther 2004; 6:1-12.
2. Libby P and Ridker PM. Inflammation and atherosclerosis. Circulation 2002; 105:1135-114. [PubMed]
3. Packard RS, Libby P. Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin Chem 2008; 54:24-38. [PubMed]
4. Li H, Cybulsky MI, Gimbrone MA, Jr., Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. ArteriosclerThromb 1993; 13(2):197-204. [PubMed]
5. Libby P. Inflammation in atherosclerosis. Nature 2002; 420(6917):868-874. [PubMed]
6. Clinton SK, Underwood R and Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992; 140:301-316. [PubMed]
7. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357:2482-2494. [PubMed]
8. Cayman Chemical. Product information, clopidogrel. Web: www.caymanchem.com.
9. Sasani M, Burak Yazgan, Irfan Celebi, et al. Hypercholesterolemia increases vasospasm resulting from basilar artery subarachnoid hemorrhage in rabbits which is attenuated by Vitamin E. Surg Neurol Int 2011; 14(2):29. [PubMed]
10. Alan Daugherty, Ben S. Zweifel & Gustav Schonfeld. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br. J. Pharmacol 1989; 98:612-618. [PubMed]
11. Hayashi T, Fukuto JM, Louis J. Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc. Nad. Acad Sci. USA 1992; 89:11259-11263. [PubMed]
12. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61:882-888. [PubMed]
13. Sonai L, Mumford. Laboratory procedure manual. Second edition, USFWS, Oillympia Fish Health Center. Olympia Washington. 2004.
14. Yung-Hsiang Chen, Shing-Jong Lin, Jaw-Wen Chen, Hung-Hai Ku and Yuh-Lien Chen. Magnolol attenuates VCAM-1 expression in vitro in TNF-α treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. British Journal of Pharmacology 2002; 135:37-47. [PubMed]
15. Gu Q, Chen JL, Ruan YM. Inhibitory effects of aspirin, clopidogrel, and their combination on the progression of atherosclerosis in rabbits. Chin Med J 2005; 27(1):87-91. [PubMed]
16. Li fang, yu suqin, Du yanhua, WANG Zheng, YE Hengtai. Clinical study of anti-inflammatory action of clopidogrel in acute coronary syndrome. Journal Clinical Cardiology 2006; 13(4):241-246.
17. Joseph B. Muhlestein. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thrombosis and Haemostasis 2010; 103:71-82. [PubMed]
18. Cha JK, Jeong MH, Lee KM et al. Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel. J Thromb Thrombolysis 2002; 14(2):145-150. [PubMed]
19. Antonis S. Manolis, Stylianos Tzeis, George Andrikopoulos et al. Aspirin and Clopidogrel: A Sweeping Combination in Cardiology. Curr. Med. Chem Cardiovascular & Hematological Agents 2005; 3:203-219. [PubMed]
20. Hadi NR, Mohammad BI, Ajeena IM, Sahib HH. Antiatherosclerotic potential of clopidogrel: antioxidant and anti-inflammatory approaches. Biomed Res Int. Biomed Res Int 2013; 2013: 790263. [PubMed]
